Verus Capital Partners’s Prothena Corp PRTA Stock Holding History

Verus Capital Partners’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3	Closed	–	–	1578
2019 Q4	$0	Buy	+3	New	+$32	﹤0.01%	1548

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Verus Capital Partners's PRTA Position: Q1 2020 in Review

Verus Capital Partners sold out of Prothena Corp (PRTA) in Q1 2020, closing a stake of 3 shares.

Verus Capital Partners first reported a position in PRTA in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 129 funds tracked by Wall St. Rank hold PRTA as of Q1 2020.

Verus Capital Partners reported no remaining Prothena Corp position as of Q1 2020 after selling out during the quarter.
Verus Capital Partners sold 3 Prothena Corp shares in Q1 2020.
Verus Capital Partners first reported a position in Prothena Corp in Q4 2019 and held it in 1 quarter.
Verus Capital Partners's Prothena Corp position peaked at $0 in Q4 2019.
129 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.